Evidence map›Paper›PMID 25922085›Full record

ArticleInfection2015

Lyme neuroborreliosis in a patient treated with TNF-alpha inhibitor.

Maja Ivartnik Merkac, Janez Tomazic, Franc Strle

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Infection, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Maja Ivartnik MerkacGeneral Hospital Slovenj Gradec, Slovenj Gradec, Slovenia.
Janez TomazicDepartment of Infectious Diseases, University Medical Centre Ljubljana, Japljeva 2, 1525, Ljubljana, Slovenia.
Franc StrleDepartment of Infectious Diseases, University Medical Centre Ljubljana, Japljeva 2, 1525, Ljubljana, Slovenia. franc.strle@kclj.si.
Ljubljana University Medical Centre · SIŠolski center Slovenj Gradec · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 57-year-old woman, receiving TNF-alpha inhibitor adalimumab for psoriasis, presented with early Lyme neuroborreliosis (Bannwarth's syndrome). Discontinuation of adalimumab and 14-day therapy with ceftriaxone resulted in a smooth course and favorable outcome of Lyme borreliosis. This is the first report on Lyme neuroborreliosis in a patient treated with TNF-alpha inhibitor.

Indexed as

AdalimumabAnti-Bacterial AgentsCeftriaxoneFemaleHumansImmunologic FactorsLyme NeuroborreliosisMiddle AgedPsoriasisTreatment OutcomeAdalimumabAnti-Bacterial AgentsCeftriaxoneImmunologic FactorsAdalimumabBannwarth’s syndromeLyme borreliosisLyme neuroborreliosisTNF-α inhibitor

Identifiers

PMID25922085
OpenAlexW2020277132

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.